Category: Newest Therapies

The relationship between the apheresis center and cell therapy developer/provider WEST WARWICK, Rhode IslandMay, 2023 An outstanding article from Suzanne Kamps of Adaptimmune in Cell & Gene Therapy Insights on the growing importance of the relationship between the apheresis center and cell therapy developer/provider. “…clearly communicating our (Adaptimmune)  message about our specific treatment and allowing…

New York Blood Center Unveils NYBC Ventures. NEW YORK, New YorkMay, 2023 Blood Centers of America member, New York Blood Center, unveils its $50 million investment fund called NYBC Ventures. This newly formed investment fund focusses on blood and cellular therapeutics. The financing for this new venture is tied to proceeds from solvent detergent plasma…

Cell therapies have made significant improvements so far in 2023 WEST WARWICK, Rhode IslandApril, 2023 So far in 2023: 1 cell therapy BLA approved by the FDA (1st expanded hematopoeitic stem cell product, 1st manufactured umbilical cord blood services product. 4 advanced therapies BLA submissions: First Iovance (1st TIL cell therapy), then Adaptimmune (1st engineered TCR…

Blood Centers of America member, LifeSouth Community Blood Centers, selected to provide CD34 cells to Zubair Abba of Mayo Clinic. WEST WARWICK, Rhode IslandMay, 2023 Blood Centers of America member LifeSouth Community Blood Centers, headquartered in Gainesville, Fla., was selected to provide umbilical cord blood-derived CD34 cells to Zubair Abba of Mayo Clinic in Florida…

Cord Blood Connect calls for abstracts to publish in STEM CELLS Translational Medicine. WEST WARWICK, Rhode IslandApril, 2023 Whether your work focuses on preclinical studies, clinical trials, perinatal tissue banking and therapies, cord blood collection, or cord blood bank management, your work is impactful to the cord blood community. Submit your abstract by June 16.…

An interview of Dr. Michael Tees and Dr. Fred Locke offering clinician views on CAR-T WEST WARWICK, Rhode IslandApril, 2023 A great interview of Dr. Michael Tees and Dr. Fred Locke by Arsalan Arif offering clinician views on current challenges and future opportunities for CAR-T (autologous + allogeneic). Link to video:  https://carttogether.com Our takeaways? (1)…

An autologous tumor infiltratating lymphocite therapy for the treatement of advanced melanoma WEST WARWICK, Rhode IslandApril, 2023 Iovance Biotherapeutics, Inc. completes their BLA submission for Lifileucel – an autologous tumor infiltrating lymphocyte (TIL) therapy (manufactured using PBMC feeder cells) for the treatment of advanced (unresectable or metastatic) melanoma who have progressed on or after prior…

A collaborative agreement to develop commercial relationships to serve unmet needs by utilizing the Symphony Platform in the blood and hospital markets WEST WARWICK, Rhode IslandFebruary 14, 2023 Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), and Blood Centers of America (BCA) today announced that they have executed a collaborative agreement to develop commercial relationships to serve…